The a2 Milk Co Ltd (ASX: A2M) Share Price and News

Price

Movement

( )

(20 mins delayed)

52 Week Range

-

 
1 Year Return

 

The a2 Milk Co Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $5.99 billion
P/E Ratio 38.56
Dividend Yield 0.79%
Shares Outstanding 724.02 million
Earnings per share 0.231
Dividend per share 0.13
Year To Date Return 44.22%
Earnings Yield 2.59%
Franking -
Share Price

Day Change

( )

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

The a2 Milk Co Ltd (ASX: A2M)
Latest News

Older man and young boy smiling while drinking milk with milk moustaches
Consumer Staples & Discretionary Shares

Here is the earnings forecast out to 2026 for A2 Milk shares

A2 Milk earnings are projected to be on a good trajectory.

Read more »

boy holding a jar watching growth of a plant
Opinions

My ASX share portfolio has two giant weeds in it. Should I pull them out?

Like the Gambler, you have to know when to fold 'em.

Read more »

Real estate agent and client exploring property.
Share Market News

How ASX shares vs. property performed in May

We reveal the property price growth for each city and regional market and the top 5 risers of the ASX…

Read more »

A young girls clings in fright to a big red slide.
Share Market News

Here are the top 10 ASX 200 shares today

Investors were hitting the sell button hard today...

Read more »

Young girl drinking milk showing off muscles.
52-Week Highs

Up 63%: The A2 Milk share price just hit a new 52-week high

A2 Milk shares can't stop winning for investors in 2024...

Read more »

A piggy bank on the cloud in the blue sky symbolising a record high share price.
52-Week Highs

Guess which 7 ASX 200 shares are smashing new 52-week highs today

Investors are sending these seven stocks soaring to new one-year highs today.

Read more »

A woman's hand draws a stylised 'Top Ten' on a projected surface.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a sobering end to the week's trading this Friday.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 was on fire today, with almost every sector surging.

Read more »

A woman wearing a flowing red dress, poses dramatically on a beach with the sea in the background.
Share Market News

Here are the top 10 ASX 200 shares today

It was a sea of red on Thursday for ASX investors.

Read more »

Happy man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors enjoyed another strong showing this Tuesday.

Read more »

A woman relaxes on a yellow couch with a book and cuppa, and looks pensively away as she contemplates the joy of earning passive income.
Consumer Staples & Discretionary Shares

What are brokers saying about A2 Milk shares?

Is it time to snap up this stock or should you keep your infant formula powder dry?

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why A2 Milk, Lindsay Australia, Meridian Energy, and Opthea shares are falling today

These ASX shares are having a tough time on Thursday. But why?

Read more »

Frequently Asked Questions

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
20 Mar 2025 $0.0650 0.00% Interim 04 Apr 2025

A2M ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

About The a2 Milk Co Ltd

A2 Milk Company Ltd (ASX: A2M) is a fresh milk and infant formula company that sources, produces and supplies a2 brand milk and milk-related products in Australia and globally.

The Company was founded in 2000 in New Zealand by scientist Dr Corran McLachlan and Howard Paterson.

The company produces fresh cows' milk that naturally contains the A2 protein type and no A1 protein. Some research suggests the A1 protein can cause digestion issues.

A2M Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
17 Apr 2025 $8.27 $0.13 1.60% 2,051,751 $8.10 $8.29 $7.96
16 Apr 2025 $8.14 $0.04 0.49% 1,496,330 $8.10 $8.18 $8.01
15 Apr 2025 $8.10 $0.04 0.50% 1,558,710 $8.14 $8.22 $8.07
14 Apr 2025 $8.06 $-0.25 -3.01% 1,566,264 $8.36 $8.40 $8.04
11 Apr 2025 $8.31 $0.10 1.22% 2,468,645 $8.00 $8.35 $7.96
10 Apr 2025 $8.21 $0.20 2.50% 3,802,768 $8.27 $8.35 $8.09
09 Apr 2025 $8.01 $0.20 2.56% 3,575,374 $7.76 $8.01 $7.76
08 Apr 2025 $7.81 $0.02 0.26% 3,592,274 $7.78 $7.92 $7.65
07 Apr 2025 $7.79 $0.01 0.13% 4,988,819 $7.50 $7.81 $7.40
04 Apr 2025 $7.78 $-0.06 -0.77% 2,532,743 $7.70 $7.84 $7.63
03 Apr 2025 $7.84 $-0.02 -0.25% 2,461,546 $7.77 $7.90 $7.74
02 Apr 2025 $7.86 $-0.03 -0.38% 1,559,256 $7.90 $7.93 $7.78
01 Apr 2025 $7.89 $-0.04 -0.50% 2,634,300 $8.04 $8.05 $7.86
31 Mar 2025 $7.93 $-0.05 -0.63% 2,561,282 $7.93 $8.13 $7.89
28 Mar 2025 $7.98 $0.09 1.14% 4,472,890 $7.89 $8.19 $7.86
27 Mar 2025 $7.89 $-0.16 -1.99% 2,676,743 $8.02 $8.02 $7.82
26 Mar 2025 $8.05 $0.03 0.37% 2,106,243 $8.00 $8.12 $7.97
25 Mar 2025 $8.02 $-0.03 -0.37% 2,038,965 $8.00 $8.09 $7.88

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
09 Dec 2024 David Bortolussi Issued 538,336 $3,063,131
Issue of securities. 1,729,582 performance rights
30 Aug 2024 David Bortolussi Buy 490,906 $2,744,164
Conversion of securities.
30 Aug 2024 David Bortolussi Exercise 490,906 $2,744,164
Conversion of securities. 1,191,246 performance rights

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr David Landt Bortolussi Chief Executive OfficerManaging Director Feb 2021
Mr Bortolussi career has been focused on the consumer and retail sector in Australia and New Zealand complemented by international experience in various markets and categories in China, SE Asia, the EU and the USA. David also has an interest in private equity and growth-phase businesses. He is a member of the advisory board of Whiteoak and supports the development of investee companies.
Ms Philippa (Pip) Mary Greenwood Non-Executive ChairmanNon-Executive Director Jul 2019
Ms Greenwood is also the Chair of Westpac New Zealand and a director of Fisher & Paykel Healthcare. She was previously a director of Spark New Zealand and Vulcan Steel. Prior to becoming a full-time director, Pip was a senior partner at law firm Russell McVeagh, where she spent over 10 years on the firm's Board including acting as the firm's Board Chair and interim CEO.
Ms Kathryn(Kate) Mitchell Non-Executive Director Jun 2023
Ms Mitchell has governance experience as a director of both private and public companies. Prior to moving to New Zealand in 2014, Kate's executive career spanned over 20 years in investment banking in London, which included senior leadership roles in the Global Markets division within investment banks including Deutsche Bank, Goldman Sachs and Merrill Lynch. She also has experience in developing solutions for clients, particularly in the areas of financial risk management, structured financing and investments. She is also Chair of the Risk Management Committee.
Ms Sandra Yu Non-Executive Director Mar 2022
Ms Yu is a company director and a global executive in consumer goods industries, and importantly in the infant milk formula (IMF) market in China, with a proven track record of driving business and brand transformation, leveraging opportunities for growth, and building organizational capabilities across China as well as the USA and other parts of Asia. Prior to that, Sandra held various other senior executive roles at Mead Johnson Nutrition, including as the Global Marketing Vice President, responsible for transition to new digital media and e-commerce channels globally.
Mr Antonio (Tonet) Rivera Non-Executive Director Nov 2024
Mr Rivera has over 35 years of supply chain experience, including 17 years of international leadership experience. Mr Rivera worked for Mead Johnson Nutrition from 2002 to 2017, in four years leading the global supply chain of the multinational nutrition company in the role of Senior Vice President, Global Supply Chain. Prior to that, he served as Vice President, Supply Chain - Asia and Europe for more than a decade, with responsibility for Supply Chain operations in Europe and Asia, including owned manufacturing locations and third-party manufacturers. Since retiring from executive roles in 2017, when Mead Johnson Nutrition was acquired by Reckitt Benckiser Group plc, Mr Rivera has worked as a supply chain consultant.
Mr Lain Jager Non-Executive Director Dec 2024
Mr Jager brings international, agribusiness leadership experience to the Board through his former role as CEO of Zespri International. Since stepping down from Zespri in 2017, Lain has on private business interests including personal investments in a range of entrepreneurial, technology and agriculture related businesses. Mr Jager is based in New Zealand. The Board has determined that Mr Jager will be an independent director. He will also be a member of the Boards People and Remuneration Committee.
Mr Jaron McVicar Company SecretaryGeneral Counsel Nov 2016
-
Jaron McVicar Company SecretaryGeneral Counsel
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
HSBC Custody Nominees (Australia) Limited 113,290,528 15.67%
Citicorp Nominees Pty Limited 96,163,814 13.30%
BNP Paribas Nominees NZ Limited Bpss40* 42,529,528 5.88%
J P Morgan Nominees Australia Pty Limited 34,661,044 4.79%
HSBC Nominees (New Zealand) Limited* 26,156,306 3.62%
Tea Custodians Limited* 21,013,734 2.91%
HSBC Custody Nominees (Australia) Limited Gsco Eca 20,980,543 2.90%
Accident Compensation Corporation* 20,509,205 2.84%
JPMORGAN Chase Bank* 18,595,095 2.57%
New Zealand Superannuation Fund Nominees Limited* 17,659,815 2.44%
Citibank Nominees (NZ) Ltd* 15,787,511 2.18%
New Zealand Depository Nominee 14,021,429 1.94%
National Nominees Limited 13,425,469 1.86%
HSBC Nominees (New Zealand) Limited* i 9,463,432 1.31%
Premier Nominees Limited* 8,473,699 1.17%
Public Trust* 7,323,398 1.01%
UBS Nominees Pty Ltd 6,938,917 0.96%
New Zealand Permanent Trustees Limited* 6,325,699 0.88%
BNP Paribas Noms Pty Ltd 6,123,304 0.85%
JBWere (NZ) Nominees Limited 5,945,531 0.82%

Profile

since

Note